A Skin Image Reference Tool to Aid Healthcare Providers' Diagnosis
ConditionDermatologic Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age10+
SponsorWake Forest University Health Sciences
About this trial
Consented patients will have three images taken of their dermatologic conditions within the Belle.ai software. These images will be uploaded and saved within the Belle software system where a single AI-generated differential list will be generated based on the three photos. All photos uploaded will be de-identified. The software will not have any unique identifiers of participants saved in the system. The photos will be named based on participant enrollment numbers or unique code numbers and no unique identifiers will be attached to the photos. There will be no data collection form necessary for this study
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient must present to an Advocate Health dermatology clinic
Patient must have the ability and willingness to provide informed consent and comply with study procedures and visits
Participant dermatologists must have access to the required technology (e.g., smartphone with internet access) and be capable of using it for the required image capture
Disqualifiers
Patients who are unable to comply with study procedures due to physical or mental health limitations (as assessed by study coordinator)
Pediatric, adolescent, and teen patients who present with dermatological conditions on their genitalia will not be included in the study (in support of patient privacy concerns).
Trial population
Up to 400 participants will be recruited for this study
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
400 Participants
are grouped into 1 trial groupGroup A: Patient at Advocate Health dermatology clinic
Trial outcomes
Primary outcomes
1
concordance of Belle.ai diagnoses with physician diagnoses.
The study coordinator will review uploaded patient "cases" and assign them for review and adjudication to designated Dermatologic Review Committee (DRC) members within the Belle web portal. The DRC will be comprised of 1-2 Advocate Health board-certified dermatologists from each of the Winston, Charlotte, and Midwest dermatology practices.
Time frame
Day 1Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Wake Forest University Health Sciences
Lead sponsor
BelleTorus Corporation
Collaborator
Source ClinicalTrials.gov